Recurring and antimicrobial-resistant infections: Considering the potential role of biofilms in clinical practice

Ostomy Wound Management

Volumn 53, Issue 4, 2007, Pages 46-62

  Saye, Donald E ^a  

^a NONE

Author keywords

Biofilms; Infection; Micro organisms; Wounds

Indexed keywords

ANTIBIOTIC RESISTANCE; BACTERIUM ADHERENCE; BIOFILM; CHRONIC DISEASE; EQUIPMENT; GENE EXPRESSION REGULATION; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFECTION CONTROL; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NECROSIS; PHYSIOLOGY; QUORUM SENSING; RECURRENT DISEASE; REVIEW; RISK FACTOR; SKIN CARE; TIME; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

BACTERIAL ADHESION; BIOFILMS; CHRONIC DISEASE; DRUG RESISTANCE, MICROBIAL; EQUIPMENT CONTAMINATION; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; NECROSIS; QUORUM SENSING; RECURRENCE; RISK FACTORS; SKIN CARE; TIME FACTORS; TREATMENT OUTCOME; WOUND HEALING; WOUND INFECTION;

EID: 34247882846     PISSN: 08895899     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318-1322.
2. Singh PK, Schaefer AL, Parsek MR, et al. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature. 2000;407(6805):762-764.
3. Baillie GS, Douglas LJ. Candida biofilms and their susceptibility to antifungal agents. Methods Enzymol. 1999;310:644-656.
4. Kuchma SL, O'Toole GA. Surface-induced and biofilm-induced changes in gene expression. Curr Opin Biotechnol. 2000;11(5):429-433.
5. Adam B, Baillie GS, Douglas LJ. Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol. 2002;51(4):344-349.
6. Pratt LA, Kolter R. Genetic analyses of bacterial biofilm formation. Curr Opin Microbiol. 1999;2(6):598-603.
7. Lamfon H, Porter SR, McCullough M, Pratten J. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother. 2004;53(2):383-385.
8. Gristina AG, Costerton JW. Bacterial adherence and the glycocalyx and their role in musculoskeletal infection. Orthoped Clin N Am. 1984;15(3):517-535.
9. Stickler D. Biofilms. Curr Opin Microbiol. 1999;2(3):270-275.
10. Guide N. NIH Guide: Research on microbial biofilms. Research on microbial biofilms cited. Available from: http://grants.nih.gov/grants/guide/pa-files/PA- 98-070.html. Accessed May 14, 1998.
11. Alam SI, Khan KA, Ahmad A. Glycocalyx-positive bacteria isolated from chronic osteomyelitis and septic arthritis. Ceylon Med J. 1990;35(1):21-23.
12. Gristina AG, Costerton JW. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am. 1985;67(2 suppl A):264-273.
13. Bos R, Van der Mei HC, Busscher H. Physico-chemistry of initial microbial adhesive interactions - its mechanisms and methods for study. FEMS Microbiol Rev. 1999;23(2):179-230.
14. Merritt K, Chang CC. Factors influencing bacterial adherence to biomaterials. J Biomater Appl. 1991;5(3):185-203.
15. Mittleman M. Biological fouling of purified-water systems: Part 1. Bacterial growth and replication. Microcontamination. 1985;3(10):51-55.
16. Cramton SE, Gerke C, Schnell NF, Nichols WW, Gotz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun. 1999;67(10):5427-5433.
17. Le Thi TT, Prigent-Combaret C, Dorel C, Lejeune P. First stages of biofilm formation: characterization and quantification of bacterial functions involved in colonization process. Methods Enzymol. 2001;336:152-159.
18. Stoodley P, Boyle JD, DeBeer D, Lappin-Scott HM. Evolving perspectives of biofilm structure. Biofouling. 1999;14(1):75-90.
19. Neu TR. Significance of bacterial surface active compounds in interaction with interfaces. Microbiol Rev. 1996;60(1):151-166.
20. Jenkinson H, Lappin-Scott HM. Biofilms adhere to stay. Trends Microbiol. 2001;9(1):9-10.
21. Palmer RJ Jr, White DC. Developmental biology of biofilms: implication for treatment and control. Trends Microbiol. 1997;5(11):435-440.
22. Rickard AH, Gilbert P, High NJ, Kolenbrander PE, Handley PS. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol. 2003;11(2):94-100.
23. Mims C. The Pathogenesis of Infectious Diseases, 3rd ed. San Diego, Calif: Academic Press;1987.
24. Patti JM, Allen BL, McGavin MJ, Hook M. MSCRAMM-mediated adherence of microorganisms to host tissue. Ann Rev Microbiol. 1994;48:585-617.
25. Kolenbrander P, et al. Biofilm matrix polymers - role in adhesion. In Newman H, Wilson W, eds. Dental Plaque Revisited. London: BioLine Publications;1999.
26. Allison D, Sutherland I, Neu T, eds. EPS: what's in an acronym? In: McBain A, ed. Biofilm Communities: Order from Chaos? Cardiff, UK: Bioline;2003.
27. Costerton JW, Irvin I, Cheng KJ. The bacterial glycocalyx in nature and disease. Ann Rev Microbiol. 1981;35:299-324.
28. Costerton JW, Cheng KJ, Geesey GG, et al. Bacterial biofilms in nature and disease. Ann Rev Microbiol. 1987;41:435-464.
29. Jahn A, Griebe T, Nielson PH. Composition of Pseudomonas putida biofilms: accumulation of protein in the biofilm matrix. Biofouling. 2000;14:49-57.
30. Sutherland I. The biofilm matrix -an immobilized but dynamic microbial environment. Trends Microbiol. 2001;9(5):222-227.
31. Sutherland IW. Biofilm exopolysaccharides: a strong and sticky framework. Trends Microbiol. 2001;9(5):222-227.
32. Flemming HC, Wingender J. Relevance of microbial extracellular polymeric substances (EPSs) - Part I: structural and ecological aspects. Water Sci Technol. 2001;43(6):1-8.
33. Wingender J, Flemming HC, Neu TR. What are bacterial extracellular polymeric substances? In: Wingender J, Neu T, Flemming H, eds. Microbial Extracellular Polymeric Substances - Characterization, Structure and Function. Berlin, Germany: Springer;1999:1-19.
34. Marshall KC. Microbial adhesion in biotechnological processes. Curr Opin Biotechnol. 1994;5(3):296-301.
35. Kumamoto C. Candida biofilms. Curr Opin Microbiol. 2002;5(6):608-611.
36. Korstgens,V, Flemming HC, Wingender J, Borchard W. Influence of calcium ions on the mechanical properties of a model biofilm of mucoid Pseudomonas aeruginosa. Water Sci Technol. 2001;43(6):49-57.
37. Murga R, Miller JM, Donlan RM. Biofilm formation by Gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol. 2001;39(6):2294-2297.
38. Shanks RM, Donegan NP, Graber ML, et al. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun. 2005;73(8):4596-4606.
39. Jones SM, Morgan M, Humphrey TJ, Lappin-Scott H. Effect of vancomycin and rifampicin on methicillin-resistant Staphylococcus aureus biofilms. Lancet. 2001;357(9249):40-41.
40. Tunney M, Jones DS, Gorman S. Biofilm and biofilm-related encrustation of urinary tract devices. In: Doyle R, ed. Methods in Enzymology. San Diego, Calif: Academic Press;1999.
41. Serralta V, Harrison-Balestra C, Cazzaniga AL, Davis SC, Mertz PM. Lifestyles of bacteria in wounds: presence of biofilms? WOUNDS. 2001;13(1):29-34.
42. Gristina AG, Naylor PT, Myrvik QN. Musculoskeletal infection, microbial adhesion, and antibiotic resistance. Infect Dis Clin N Am. 1990;4(3):391-408.
43. Webb LX, Hobgood CD, Meredith JW, Gristina AG. Adhesive bacterial colonization of exposed traumatized tendon. Orthop Rev. 1987;16(5):304-309.
44. Akiyama H, Yamasaki O, Kanzaki H, Tada J, Arata J. Effects of sucrose and silver on Staphylococcus aureus biofilms. J Antimicrob Chemother. 1998;42(5):629-634.
45. Post JC, Stoodley P, Hall-Stoodley L, Ehrlich GD. The role of biofilms in otolaryngologic infections. Curr Opin Otolaryngol Head Neck Surg. 2004;12(3):185-190.
46. Lambe DW Jr, Ferguson KP, Mayberry-Carson KJ, Tober-Meyer B, Costerson JW. Foreign-body associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthopaed. 1991;266:285-294.
47. Bruinsma G. Detergents in biofilm detachment. Biomed Engineer.
48. Gristina A, Rovere G, Shoji H. Spontaneous septic arthritis complicating rheumatoid arthritis. JBJS. 1974;56A:30-35.
49. Marrie TJ, Lam J, Costerton JW. Bacterial adhesion to uroepithelial cells: a morphologic study. J Infect Dis. 1980;142(2):239-246.
50. Eden CS, Eriksson B, Hanson LA. Adhesion of Escherichia coli to human uroepithelial cells in vitro. J Immun. 1977;18(3):767-774.
51. Katz S, Izhar M, Mirelman D. Bacterial adherence to surgical sutures. A possible factor in suture-induced infection. Ann Surg. 1981;194(1):35-41.
52. Kendall RW, et al. Persistence of bacteria on antibiotic loaded acrylic depots. Clin Orthopaed Related Res. 1996;329:273-280.
53. Gristina AG, Oga M, Webb LX, Hobgood CD. Adherent bacterial colonization in the pathogenesis of osteomyelitis. Science. 1985;228(4702):990-993.
54. van de Belt H, Neut D, Schenk W, et al. Staphylococcus aureus biofilm formation on different gentamicin-loaded polymethylmethacrylate bone cements. Biomaterials. 2001;22(12):1607-1611.
55. van de Belt H, Neut D, Schenk W, et al. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthop Scand. 2000;71(6):625-629.
56. Gracia E, Fernandez A, Conchello P, et al. Adherence of Staphylococcus aureus slime-producing strain variants to biomaterials used in orthopaedic surgery. Int Orthop. 1997;21(1):46-51.
57. Vuong C, Saenz HL, Gotz F, Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J Infect Dis. 2000;182(6):1688-1693.
58. Buxton TB, Horner J, Hinton A, Rissing JP. In vivo glycocalyx expression by Staphylococcus aureus phage type 52/52A/80 in S. aureus osteomyelitis. J Infect Dis. 1987;156(6):942-946.
59. Arciola C, Baldassarri L, Montanaro L. Presence of icaA and icaD genes and slime production in a collection of staphylococcal strains from catheter-associated infections. J Clin Microbiol. 2001;39(6):2151-2156.
60. Stickler DJ, Morris NS, McLean RJ, Fuqua C. Biofilms on indwelling urethral catheters produce quorum sensing signal molecules in situ and in vitro. App Environ Microbiol. 1998;64(9):3486-3490.
61. Whiteley M, Parsek MR, Greenberg EP. Regulation of quorum sensing by RpoS in Pseudomonas aeruginosa. J Bacteriol. 2000;182(15):4356-4360.
62. Strauss EJ, Falkow S. Microbial pathogenesis: genomics and beyond. Science. 1997;276(5313):707-712.
63. Swift S, Throup JP, Williams P, Salmond GP, Steward GS. Quorum sensing: a population-density component in the determination of bacterial phenotype. Trends Biochem Sci. 1996;21(6):214-219.
64. Parsek MR, Greenberg EP. Acyl-homoserine lactone quorum sensing in gram-negative bacteria: a signaling mechanism involved in associations with higher organisms. Proc Natl Acad Sci USA. 2000;97(16):8789-8793.
65. Davies DG, Parsek MR, Pearson JP, et al. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998;280(5361):295- 298.
66. Bollinger N, Hassett DJ, Iglewski BH, Costerton JW, McDermott TR. Gene expression in Pseudomonas aeruginosa: evidence of iron override effects on quorum sensing and biofilm specific gene regulation. J Bacteriol. 2001;183(6):1990-1996.
67. Hoyle BD, Costerton JW. Bacterial resistance to antibiotics: the role of biofilms. Prog Drug Res. 1991;37:91-105.
68. Rijnaarts HH, Norde W, Bouwer EJ, Lyklema J. Bacterial adhesion under static and dynamic conditions. Appl Environ Microbiol. 1993;59(10):3255-3265.
69. Jackson DW, Suzuki K, Oakford L, et al. Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J Bacteriol. 2002;184(1):290-301.
70. Mayette D. The existence and significance of biofilms in water. Water Review. 1992:1-3.
71. Patterson MK, Husted GR, Rutkowski A, Mayette DC. Isolation, identification and microscopic properties of biofilms in high-purity water distribution systems. Ultrapure Water. 1991;8(4):18-24.
72. Costerton JW, Khoury AE, WArd KH, Anwar H. Practical measures to control device-related bacterial infections. Int J Artif Organs. 1993;16(11):765-770.
73. Khoury A, Lam K, Ellis BD, Costerton JW. Prevention and control of bacterial infections associated with medical devices. Am Soc Artif Intern Organs J. 1991;38(3):M174-M178.
74. Dougherty SH, Simmons RL. Endogenous factors contributing to prosthetic device infections. Infect Dis Clin North Am. 1989;3(2):199-209.
75. Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237(H822):1588-1595.
76. Dunne W Jr, Mason E, Kaplan S. Diffusion of rifampin and vancomycin through a Staphylococcus epidermidis biofilm. Antimicrob Agents Chemother. 1993;37(12):2522-2526.
77. Darouiche RO, Dhir A, Miller AJ. Vancomycin penetration into biofilm covering infected prostheses and effect on bacteria. J Infect Dis. 1994;170(3):720-723.
78. Chandy JP, Angles ML. Determination of nutrients limiting biofilm formation and the subsequent impact on disinfectant decay. Water Res. 2001;35(11):2677-2682.
79. Yasuda H, Ajiki Y, Aoyama J, Yokota T. Interaction between human polymorphonuclear leucocytes and bacteria released from in-vitro bacterial biofilm models. J Med Microbiol. 1994;41(5):359-367.
80. Stewart PS. A review of experimental measurements of effective diffusive permeabilities and effective diffusion coefficients in biofilms. Biotechnol Bioeng. 1998;59(3):261-272.
81. Wilcox MH, Kite P, Mills K, Sugden S. In situ measurement of linezolid and vancomycin concentrations in intravascular catheter-associated biofilm. J Antimicrob Chemother. 2001;47(2):171-175.
82. Gander S. Bacterial biofilms: resistance to antimicrobial agents. J Antimicrob Chemother. 1996;37(6):1047-1050.
83. Zheng Z, Stewart PS. Penetration of rifampin through Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother. 2002;46(3):900-903.
84. Nickel JC, Ruseka I, Wright JB, Costerton JW. Tobramycin resistance of cells of Pseudomonas aeruginosa growing as a biofilm on urinary catheter material. Antimicrob Agents Chemother. 1985;27(4):619-624.
85. Sepandj F, Ceri H, Gibb A, Read R, Olson M. Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of Gram-negative bacilli causing peritonitis. Perit Dial Int. 2004;24(1):65-67.
86. Dreeszen P. The key to understanding and controlling bacterial growth in automated drinking water systems. Available at: www.edstrom.com/DocLib/biofilm. pdf. Accessed January 31, 2005.
87. Kumon H. Management of biofilm infections in the urinary tract. World J Surg. 2000;24(10):1193-1196.
88. Stewart PS. Multicellular resistance: biofilms. Trends Microbiol. 2001;9(5):204.
89. Schwank S, Rajacic Z, Zimmerli W, Blaser J. Impact of bacterial biofilm formation on in vitro and in vivo activities of antibiotics. Antimicrob Agents Chemother. 1998;42(4):895-898.
90. Mah T, O'Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 2001;9(1):34-39.
91. Sheldon A Jr. Antibiotic resistance: a survival strategy. Clin Lab Sci. 2005;18(3):170-180.
92. Wimpenny J. An overview of biofilms as functional communities. In: Allison D, Gilbert P, Lappin-Scott HM, Wilson M, eds. SGM Symposium. Cambridge, UK: Cambridge University Press;2000:1-24.
93. Marsh P, Bradshaw D. Microbial community interactions in biofilms, In: Allison D, Gilbert P, Lappin-Scott HM, Wilson M, eds. SGM Symposium. Cambridge, UK: Cambridge University Press;2000:167-198.
94. Gilbert P, Maira-Litran T, McBain AJ, Rickard AH, Whyte FW. The physiology and collective recalcitrance of microbial biofilm communities. Adv Microb Physiol. 2002;46:202-256.
95. Miller MB, Bassler BL. Quorum sensing in bacteria. Ann Rev Microbiol. 2001;55(1):165-199.
96. Riedel K, Hentzer M, Geisenberger O, et al. N-acylhomoserine-lactone- mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology. 2001;147(12):3249-3262.
97. Davey ME, O'Toole GA. Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev. 2000;64(4):847-867.
98. Moller S, Sternberg C, Andersen JB, et al. Gene expression in mixed culture biofilms: evidence of metabolic interactions between community members. Appl Environ Microbiol. 1998;64(2):721-732.
99. Nielsen AT, Tolker-Nielsen T, Barken KB, Molin S. Role of commensal relationships on the spatial structure of a surface-attached microbial consortium. Environ Microbiol. 2000;2(1):59-68.
100. Cowan S, Gilbert E, Liepmann D, Keasling JD. Commensal interactions in a dual species biofilm exposed to mixed organic compounds. Appl Environ Microbiol. 2000;66(10):4481-4485.
101. Lawrence JR, Korber DR, Wolfaardt GM, Caldwell DE. Behavioral strategies of surface-colonizing bacteria. Adv Microb Ecol. 1995;14:1-75.
102. Anwar H, Strap JL, Costerton JW. Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy. Antimicrob Agents Chemother. 1992;36(7):1347-1351.
103. Brown ML, Aldrich HC, Gauthier JJ. Relationship between glycocalyx and povidone-iodine resistance in Pseudomonas aeruginosa (ATCC 27853) biofilms. Appl Environ Microbiol. 1995;61(1):187-193.
104. Amorena B, Gracia E, Monzon M, et al. Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother. 1999;44(1):43-55.
105. Evans K, Passador L, Srikumar R, et al. Influence of the MexAB-OprM Multidrug Efflux System on quorum sensing in Pseudomonas aeruginosa. J Bacteriol. 1998;180(20):5443-5447.
106. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob Agents Chemother. 2000;44(7):1818-1824.
107. Stewart P. Theoretical aspects of antibiotic diffusion into microbial biofilms. Antimicrob Agents Chemother. 1996;40(11):2517-2522.
108. Shigeta M, Tanaka G, Komatsuzawa H, et al. Permeation of antimicrobial agents through Pseudomonas aeruginosa biofilms: a simple method. Chemotherapy. 1997;43(5):340-345.
109. Vrany JS, Stewart PS, Suci P. Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa biofilms displaying rapid-transport characteristics. Antimicrob Agents Chemother. 1997;41(6):1352.
110. Brooun A, Liu S, Lewis K. A dose-response study of antibiotic resistance in Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother. 2000;44(3):640-646.
111. Cochran WL, McFeters GA, Stewart PS. Reduced susceptibility of thin Pseudomonas aeruginosa biofilms to hydrogen peroxide and monochloramine. J Appl Microbiol. 2000;88:22-30.
112. Ishida H, Ishida Y, Kurosaka Y, et al. In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1998;42(7):1641-1645.
113. Veringa EM, Ferguson DA Jr, Lambe DW Jr, Verhoef J. The role of glycocalyx in surface phagocytosis of Bacteroides spp. in the presence and absence of clindamycin. J Antimicrob Chemother. 1989;23(5):711-720.
114. Szomolay B, Klapper I, Dockery J, Stewart PS. Adaptive responses to antimicrobial agents in biofilms. Environ Microbiol. 2005;7(8):1186-1191.
115. Lewis K. Programmed death in bacteria. Microbiol Mol Biol. 2000;64(3):503-514.
116. Lewis K. Riddle of biofilm resistance. Antimicrob Agents Chemother. 2001;45(4): 999-1007.
117. Sternberg C, Christensen BB, Johansen T, et al. Distribution of bacterial growth activity in flow-chamber biofilms. Appl Environ Microbiol. 1999;65(9):4108-4117.
118. Evans DJ, Allison DG, Brown MR, Gilbert P. Susceptibility of Escherichia coli and Pseudomonas aeruginosa biofilms toward ciprofloxacin: effect of specific growth rate. J Antimicrob Chemother. 1991;27:177-184.
119. Duguid IG, Evans E, Brown MR, Gilbert P. Growth-rate independent killing by ciprofloxacin of biofilm derived Staphylococcus epidermidis: evidence for cell-cycle dependency. J Antimicrob Chemother. 1992;30(6):791-802.
120. Evans DJ, Brown MR, Allison DG, Gilbert P. Susceptibility of bacterial biofilms to tobramycin: role of specific growth rate and phase in the division cycle. J Antimicrob Chemother. 1990;25(4):585-591.
121. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence of a local granulocyte defect. J Clin Invest. 1984;73(4):1191-1200.
122. Vaudaux P, Zulian G, Huggler E, Waldvogel FA. Attachment of Staphylococcus aureus to polymethylmethacrylate increases it resistance to phagocytosis in foreign body infection. Infect Immun. 1985;50(2):472-477.
123. Gelosia A, Baldassarri L, Deighton M, van Nguyen T. Phenotypic and genotypic markers of Staphylococcus epidermidis virulence. Clin Microbiol Infect. 2001;7(4):193-199.
124. Becker P, Hufnagle W, Peters G, Herrmann M. Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational - difference analysis. Appl Environ Microbiol. 2001;67(7):2958-2965.
125. Foley I, Gilbert P. In-vitro studies of the activity of glycopeptide combinations against Enterococcus faecalis biofilms. J Antimicrob Chemother. 1997;40(5):667-672.
126. de Kievit T, Seed PC, Nezezon J, Passador L, Iglewski BH. RsaL, a novel repressor of virulence gene expression in Pseudomonas aeruginosa. J Bacteriol. 1999;181(7):2175-2184.
127. Braga PC, Sasso MD, Sala MT. Sub-MIC concentrations of cefodizime interfere with various factors affecting bacterial virulence. Antimicrob Chemotherap. 2000;45(1):15-25.
128. Gilbert P, Brown MRW. Phenotypic plasticity and mechanisms of protection of bacterial biofilms from antimicrobial agents. In: Lappin-Scott H, Costerton JW, eds. Microbial Biofilms. Cambridge, UK: Cambridge University Press;1995:118-132.
129. Hamilton-Miller JM, Shah S. Activity of quinupristin/dalfopristin against Staphylococcus epidermidis in biofilms: a comparison with ciprofloxacin. J Antimicrob Chemother. 1997;39(suppl A): S103-S108.
130. Konig C, Schwank S, Blaser J. Factors compromising antibiotic activity against biofilms of Staphylococcus epidermidis. Eur J Clin Microbiol Infec Dis. 1991;20(1):20-26.
131. Coughlan A. Slime city. New Scientist. 1996;15(2045):32-36.
132. Kaeberlein T, Lewis K, Epstein SS. Isolating "uncultivable" microorganisms in pure culture in a simulated natural environment. Science. 2002;296(5570):1127-1129.
133. Pace N. A molecular view of microbial diversity and the biosphere. Science. 1997;276(5313):734-740.
134. Amann R, Ludwig W, Schleifer KH. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev. 1995;59(1):143-169.
135. Relman DA. The identification of uncultured microbial pathogens. J Infect Dis. 1993;168(1):1-8.
136. Relman DA. The search for unrecognized pathogens. Science. 1999;284(5418):1308-1310.
137. Whitman WB, Coleman DC, Wiebe WJ. Prokaryotes: the unseen majority. Proc Natl Acad Sci USA. 1998;95(12):6578-6583.
138. Boyd A, Chakrabarty AM. Pseudomonas aeruginosa biofilms: role of the alginate exopolysaccharide. J Ind Microbiol. 1995;15(3):162-168.
139. Hussain M, Wilcox MH, White PJ. The slime of coagulase-negative staphylococci: biochemistry and relation to adherence. FEMS Microbiol Rev. 1993;10(3-4):191-207.
140. Brown MR, Barker J. Unexplored reservoirs of pathogenic bacteria: protozoa and biofilms. Trends Microbiol. 1999;7(1):46-50.
141. Tollefson DF, Bandyk DF, Kaebnick HW, Seabrook GR, Towne JB. Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses. Arch Surg. 1987;122(1):38-43.
142. Pajkos A, Deva AK, Vickery K, et al. Detection of subclinical infection in significant breast implant capsules. Plast Reconstr Surg. 2003;111(5):1605-1611.
143. Relman DA, Falkow S. Identification of uncultured microorganism: expanding the spectrum of characterized microbial pathogens. Infect Agents Dis. 1992;1(5):245-253.
144. Loesche WJ, Lopatin DE, Stoll J, van Poperin N, Hujoel PP. Comparison of various detection methods for periodontopathic bacteria: can culture be considered the primary reference standard. J Clin Microbiol. 1992;30(2):418-426.
145. Amann R, Kuhl M. In situ methods for assessment of microorganisms and their activities. Curr Opin Microbiol. 1998;1(3):352-358.
146. Arciola CR, Collamati S, Donati E, Montanaro L. A rapid PCR method for the detection of slime-producing strains of Staphylococcus epidermidis and S. aureus in periprosthesis infections. Diagn Mol Pathol. 2001;10(2):130-137.
147. Mietzner BA, Mietzner TA, eds. Microbial Pathogenesis: A Principles-Oriented Approach. Madison, Conn: Fence Creek Publishing;1999.